Samil Pharm (000520)

Currency in KRW
8,350
-260(-3.02%)
Closed·
Trading near 52-week Low
000520 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8,2008,660
52 wk Range
8,20012,860
Key Statistics
Bid/Ask
8,350.00 / 8,370.00
Prev. Close
8,610
Open
8,610
Day's Range
8,200-8,660
52 wk Range
8,200-12,860
Volume
334.57K
Average Volume (3m)
283.81K
1-Year Change
-34.8165%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000520 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13,000
Upside
+55.69%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 13,000
(+55.69% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
18/03/2026
EPS / Forecast
-526.06 / --
Revenue / Forecast
53B / --
EPS Revisions
Last 90 days

Compare 000520 to Peers and Sector

Metrics to compare
000520
Peers
Sector
Relationship
P/E Ratio
−5.6x6.3x−0.5x
PEG Ratio
0.010.020.00
Price/Book
1.5x1.2x2.6x
Price / LTM Sales
0.9x1.0x3.2x
Upside (Analyst Target)
41.6%51.7%50.4%
Fair Value Upside
Unlock11.3%7.2%Unlock

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.

Employees
583

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
189.67K0.89%1.64B
Other Institutional Investors
633.87K2.99%5.48B
Public Companies & Retail Investors
20.41M96.12%176.51B
Total
21.23M100.00%183.64B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
DFA Investment Dimensions Group Inc. - Emerging Markets Core Equity 2 Portfolio0.38%81,400700,854
DFA Investment Trust Company - Emerging Markets Small Cap Series0.17%36,805316,891

People Also Watch

119,100
103590
-10.65%
338,500
000500
-15.16%
52,000
005090
+1.17%
95,200
000640
-1.55%
6,530
000370
-4.67%

FAQ

What Is the Samil Pharm (Seoul: 000520) Share Price Today?

The Samil Pharm stock price today is 8,350 KRW.

What Stock Exchange Does Samil Pharm (000520) Trade On?

Samil Pharm is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Samil Pharm?

The stock symbol (also called a 'ticker') for Samil Pharm is "000520."

What Is the Current Samil Pharm Market Capitalisation?

As of today, Samil Pharm (Seoul: 000520) market cap is 177.27B KRW.

What Is Samil Pharm's (000520) Earnings Per Share (TTM)?

The Samil Pharm EPS is currently -1,633 (Trailing Twelve Months).

Is 000520 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Samil Pharm moving averages and other technical indicators, the daily buy/sell signal for 000520 stock is Strong Sell.

How Many Times Has Samil Pharm Stock Split?

Samil Pharm has split 6 times. (See the 000520 stock split history page for full effective split date and price information.)

How Many Employees Does Samil Pharm Have?

Samil Pharm has 583 employees, based on their latest Companies House report.

What is the current trading status of Samil Pharm (Seoul: 000520)?

As of 15/05/2026, Samil Pharm (000520) is trading at a share price of 8,350 KRW, with a previous close of 8,610 KRW. The stock has fluctuated within a day range of 8,200 KRW to 8,660 KRW, while its 52-week range spans from 8,200 KRW to 12,860 KRW.

What Is Samil Pharm (000520) Price Target According to Analysts?

The average 12-month price target for Samil Pharm is 13,000 KRW, with a high estimate of 13000 KRW and a low estimate of 13000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +55.69% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.